With $30M Investment, Regenacy Plans Phase 2 Trial Testing Ricolinostat for CMT Type 2 April 3, 2020With $30M Investment, Regenacy Plans Phase 2 Trial Testing Ricolinostat for CMT Type 2 With $30M Investment, Regenacy Plans Phase 2 Trial Testing Ricolinostat for CMT Type 2
